Ticker > Company >

Arvee Laboratories share price

Arvee Laboratories (India) Ltd.

NSE: ARVEE SECTOR: Chemicals  22k   23   2

154.44
-0.78 (-0.50%)
NSE: 22 Nov 03:42 PM

Price Summary

Today's High

₹ 157.49

Today's Low

₹ 153

52 Week High

₹ 315

52 Week Low

₹ 116.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

170.19 Cr.

Enterprise Value

170.3 Cr.

No. of Shares

1.1 Cr.

P/E

74.75

P/B

5.48

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  28.16

CASH

0.89 Cr.

DEBT

1 Cr.

Promoter Holding

73.5 %

EPS (TTM)

₹  2.07

Sales Growth

52.12%

ROE

15.84 %

ROCE

23.35%

Profit Growth

60.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year52.12%
3 Year10.54%
5 Year5.13%

Profit Growth

1 Year60.04%
3 Year21.46%
5 Year30.48%

ROE%

1 Year15.84%
3 Year13.53%
5 Year13.75%

ROCE %

1 Year23.35%
3 Year17.56%
5 Year16.51%

Debt/Equity

0.0356

Price to Cash Flow

58.11

Interest Cover Ratio

16.8919589117014

CFO/PAT (5 Yr. Avg.)

2.04009324613991

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.50 0.00
Jun 2024 73.50 0.00
Mar 2024 73.50 0.00
Dec 2023 73.50 0.00
Sep 2023 73.50 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.131365 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 16.8919589117014.
  • The company has an efficient Cash Conversion Cycle of 21.0259597196432 days.
  • Company has a healthy liquidity position with current ratio of 2.44011903465007.
  • The company has a good cash flow management; CFO/PAT stands at 2.04009324613991.
  • The company has a high promoter holding of 73.5%.

 Limitations

  • The company has shown a poor revenue growth of 10.5399612731665% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 32.6285.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 8.91 7.7 6.14 10.6 12.53
Total Expenditure 8.22 7.17 5.35 9.07 11.02
Operating Profit 0.69 0.52 0.8 1.54 1.5
Other Income 0.09 0.19 0.21 0.11 0.16
Interest 0.08 0.05 0.05 0.08 0.05
Depreciation 0.42 0.35 0.37 0.31 0.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.28 0.32 0.58 1.26 1.31
Tax 0.07 0.08 0.46 0.32 0.33
Profit After Tax 0.21 0.24 0.12 0.94 0.98
Adjusted EPS (Rs) 0.19 0.22 0.11 0.85 0.89

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 54.9 45.42 47.38 40.33 61.35
Total Expenditure 48.73 39.4 41.34 34.7 54.07
Operating Profit 6.17 6.02 6.04 5.62 7.28
Other Income 0.35 0.35 0.58 0.52 1.35
Interest 1.63 0.99 0.58 0.37 0.39
Depreciation 2.35 2.29 2.41 2.32 2.08
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.54 3.09 3.64 3.45 6.17
Tax 0.28 0.79 0.96 0.88 2.05
Net Profit 2.26 2.3 2.68 2.57 4.12
Adjusted EPS (Rs.) 2.05 2.09 2.43 2.34 3.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 5.51 5.51 11.02 11.02 11.02
Total Reserves 10.95 13.25 10.42 12.92 17.04
Borrowings 3.47 1.96 1 1 1
Other N/C liabilities 0.57 0.42 0.31 0.2 0.78
Current liabilities 16.65 12.49 18.29 13.54 8.84
Total Liabilities 37.15 33.62 41.05 38.68 38.69
Assets
Net Block 12.65 13.18 13.81 13.84 12.68
Capital WIP 2.32 1.78 0.97 0.98 1.53
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.57 0.69 0.65 0.17 0.54
Other N/C Assets 0.19 0.13 0.07 0 2.36
Current Assets 21.42 17.84 25.55 23.69 21.57
Total Assets 37.15 33.62 41.05 38.68 38.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 2.54 3.09 3.64 3.45 6.17
Adjustment 3.5 2.9 2.4 2.3 2.16
Changes in Assets & Liabilities 3.76 5.12 -3.37 -0.78 -3.64
Tax Paid -0.28 -0.79 -0.96 -0.95 -1.75
Operating Cash Flow 9.46 10.31 1.71 4.02 2.93
Investing Cash Flow -2.85 -3.08 -0.6 0.06 -1.26
Financing Cash Flow -4.92 -9.9 4.52 -6.05 -2.42
Net Cash Flow 1.68 -2.67 5.63 -1.98 -0.75

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.50 73.50 73.50 73.50 73.50
chandrabalaben patel 0.02 0.02 0.02 0.02 0.02
forum saumil chokshi 0.02 0.02 0.02 0.02 0.02
kavita shalin chokshi 12.15 12.15 12.15 12.15 12.15
khushbuben shalinbhai pat... 0.02 0.02 0.02 0.02 0.02
mitaben bharatbhai choksh... 24.57 24.57 24.57 24.57 24.57
shalin bharatbhai chokshi... 0.01 0.01 0.01 0.01 0.01
shalin sudhakarbhai patel... - 36.68 36.68 36.68 36.68
shalinbhai sudhakarbhai p... 0.02 0.02 0.02 0.02 0.02
sudhakar chhotabhai patel... 0.02 0.02 0.02 0.02 0.02
nshalin sudhakarbhai pate... 36.68 - - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 26.50 26.50 26.50 26.50 26.50
deval pranav patel 5.19 5.19 5.19 5.19 5.19
gitaben dinehsbhai patel 9.98 - 9.98 9.98 9.98
jashbhai patel 4.79 4.79 4.79 4.79 4.79
madhuben jashbhai patel 3.70 3.70 3.70 3.70 3.70
gitaben dineshbhai patel - 9.98 - - -

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Arvee Laboratories Stock Price Analysis and Quick Research Report. Is Arvee Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Arvee Laboratories stock price today is Rs 154.44. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Arvee Laboratories . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Arvee Laboratories has a PE ratio of 74.745910366857 which is high and comparatively overvalued .

  • Share Price: - The current share price of Arvee Laboratories is Rs 154.44. One can use valuation calculators of ticker to know if Arvee Laboratories share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Arvee Laboratories has ROA of 10.6475276996824 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Arvee Laboratories has a Current ratio of 2.44011903465007 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Arvee Laboratories has a ROE of 15.8429612899603 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Arvee Laboratories has a Debt to Equity ratio of 0.0356 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Arvee Laboratories has reported revenue growth of 52.1223650463119 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Arvee Laboratories for the current financial year is 11.8694656300905 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Arvee Laboratories is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Arvee Laboratories is Rs 2.0662 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Arvee Laboratories in Ticker for free. Also, one can get the intrinsic value of Arvee Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Arvee Laboratories
X